Document is current
Any future updates will be listed below
-
Authors
Dedon, Liv R.
Yuan, Hanshu
Chi, Jinhua
Gu, Haiwei
Arias, Albert J.
Covault, Jonathan M.
Zhou, Yanjiao
-
Funding
Funding for this research was provided by:
National Institute on Alcohol Abuse and Alcoholism (AA007290, AA12722313, AA027858)
- License Information
-
More Information
Article History
Received: 22 October 2024
Accepted: 26 February 2025
First Online: 26 March 2025
Declarations
:
: The authors declare no competing interests.
: AJA is a consultant to Sobrera Pharmaceuticals. All other authors report no conflict of interest.
: Participants were recruited from the community at three sites (two in Connecticut and one in Virginia) as part of a double-blind, randomized, placebo-controlled study investigating the use of zonisamide in reducing drinking (ClinicalTrials.gov identifier: NCT02900352, Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action (Z-Comp), first registered 14/09/2016
